Investors & Media

News

January 10, 2022

NGM Bio Outlines 2022 Strategic Priorities Across Its Portfolio of Clinical-Stage Oncology, Retinal and Liver and Metabolic Programs

January 6, 2022

NGM Bio to Present at 40th Annual J.P. Morgan Healthcare Conference

Contact Information

investor relations

ir@ngmbio.com

media relations

media@ngmbio.com